Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
4
50%
Ph early_phase_1
2
25%
Ph phase_1
1
13%
Ph phase_2
1
13%

Phase Distribution

3

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
2(25.0%)
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(6)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting3
Not yet recruiting2
Completed1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 12 (25.0%)
Phase 11 (12.5%)
Phase 21 (12.5%)
N/A4 (50.0%)

Trials by Status

completed113%
recruiting113%
active_not_recruiting338%
unknown113%
not_yet_recruiting225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8